« Previous Next » International Journal of Antimicrobial Agents
Volume 35, Issue 4 , Pages 357-361 , April 2010

The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models

Dora Szabo
- Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary
- These authors contributed equally to this study.
Eszter Ostorhazi
- Microbiology Laboratory, Department of Dermatology, Venereology and Dermato-oncology, Semmelweis University, Budapest, Hungary
- These authors contributed equally to this study.
Annegret Binas
- AiCuris GmbH & Co. KG, Wuppertal, Germany
Ferenc Rozgonyi
- Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary
- Microbiology Laboratory, Department of Dermatology, Venereology and Dermato-oncology, Semmelweis University, Budapest, Hungary
Bela Kocsis
- Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary
Marco Cassone
- Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA 19122, USA
John D. Wade
- Howard Florey Institute, University of Melbourne, Victoria 3010, Australia
- School of Chemistry, University of Melbourne, Victoria 3010, Australia
Oliver Nolte
- AiCuris GmbH & Co. KG, Wuppertal, Germany
Laszlo Otvos Jr
- Department of Biology, Temple University, Philadelphia, PA 19122, USA
- Corresponding author. Present address: Temple University, BioLife Sciences Building, 1900 North 12th Street, Philadelphia, PA 19122, USA. Tel.: +1 215 204 4020; fax: +1 215 204 6646.